Dr. Jonathan T. Lin, M.D.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 459
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
NY license 274952
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
Medical groups
- The Rogosin Institute, Inc. (23 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 459
- Services billed
- 12,660
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 803 | 280 |
| Insertion of needle into vein for collection of blood sample | 171 | 96 |
| Established patient office or other outpatient visit, 30-39 minutes | 123 | 78 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 118 | 78 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 89 | 88 |
| Hemodialysis procedure with physician evaluation | 65 | 44 |
| Established patient office or other outpatient visit, 20-29 minutes | 56 | 43 |
| Dialysis procedure including 1 evaluation | 52 | 29 |
| New patient office or other outpatient visit, 45-59 minutes | 35 | 35 |
| Hospital discharge day management, 30 minutes or less | 25 | 23 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Losartan Potassium Other prescribers in New York, NY | 125 |
| Amlodipine Besylate Other prescribers in New York, NY | 99 |
| Prednisone Other prescribers in New York, NY | 82 |
| Jardiance (empagliflozin) Other prescribers in New York, NY | 74 |
| Mycophenolate Mofetil Other prescribers in New York, NY | 64 |
| Atorvastatin Calcium Other prescribers in New York, NY | 57 |
| Farxiga (dapagliflozin propanediol) Other prescribers in New York, NY | 45 |
| Nifedipine Er (nifedipine) Other prescribers in New York, NY | 45 |
| Cyclosporine Modified (cyclosporine, modified) | 44 |
| Tamsulosin Hcl Other prescribers in New York, NY | 42 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 3 payments worth $63.15 in total to this clinician.
| Scpharmaceuticals Inc. | $32.57 |
|---|---|
| Travere Therapeutics, Inc. | $15.72 |
| Astellas Pharma US Inc | $14.86 |
| Food and Beverage | $63.15 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $27,517 in research payments for these studies, mostly to the institutions running them.
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Povetacicept in Adults With Immunoglobulin A Nephropathy (RAINIER)
Vertex Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.